Trinity Hypertension & Metabolic Research Institute Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT03635125
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Trinity Hypertension & Metabolic Research Institute

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 4)

Hypertrophy (Phase 4)

Hypertrophy, Left Ventricular (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4